Not signed in

Want to take part in these discussions? Sign in if you have an account, or apply for one below

• Forgot your password?
• Apply for membership

1. • CommentRowNumber1.
   • CommentAuthorUrs
   • CommentTimeFeb 18th 2012
   • PermaLink
   Author: Urs
   Format: MarkdownItexBen Webster created _[[symplectic duality]]_. See his message at the $n$Café [here](http://golem.ph.utexas.edu/category/2012/02/young_researchers_workshop_on.html#c040863).

   Ben Webster created symplectic duality.

   See his message at the $n$Café here.

2. • CommentRowNumber2.
   • CommentAuthorUrs
   • CommentTimeFeb 18th 2012
   • (edited Feb 18th 2012)
   • PermaLink
   Author: Urs
   Format: MarkdownItexI have done some trivial editing to _[[symplectic duality]]_, such as adding of further hyperlinks, of a floating TOC, of a _References_-section.

   I have done some trivial editing to symplectic duality, such as adding of further hyperlinks, of a floating TOC, of a References-section.

3. • CommentRowNumber3.
   • CommentAuthorBen Webster
   • CommentTimeFeb 18th 2012
   • PermaLink
   Author: Ben Webster
   Format: TextThanks for the edits. I actually tried to post about this here yesterday, but the software wouldn't let me start a thread, so I settled for posting a comment on the NCC. Anyways, as I said there, I'm very appreciative of any input people have, and hope we can get some energy around page in the lead-up to the conference mentioned at the bottom.

   Thanks for the edits. I actually tried to post about this here yesterday, but the software wouldn't let me start a thread, so I settled for posting a comment on the NCC. Anyways, as I said there, I'm very appreciative of any input people have, and hope we can get some energy around page in the lead-up to the conference mentioned at the bottom.
4. • CommentRowNumber4.
   • CommentAuthorDavid_Corfield
   • CommentTimeFeb 20th 2012
   • PermaLink
   Author: David_Corfield
   Format: MarkdownItexI look forward to seeing if this work can be given the [[nPOV]] treatment.

   I look forward to seeing if this work can be given the nPOV treatment.